Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Net Income of -$20.20 million for fiscal year 2025.
HERON THERAPEUTICS, INC. /DE/ Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$20.20M | -48.7% |
| 2024 | -$13.58M | +87.7% |
| 2023 | -$110.56M | +39.3% |
| 2022 | -$182.02M | +17.5% |
| 2021 | -$220.68M | +2.9% |
| 2020 | -$227.28M | -11.0% |
| 2019 | -$204.75M | -14.5% |
| 2018 | -$178.84M | +9.4% |
| 2017 | -$197.48M | -14.1% |
| 2016 | -$173.14M | -77.4% |
| 2015 | -$97.59M | -27.8% |
| 2014 | -$76.37M | -38.1% |
| 2013 | -$55.28M | -136.8% |
| 2012 | -$23.35M | -97.6% |
| 2011 | -$11.81M | -60.8% |
| 2010 | -$7.35M | +26.7% |
| 2009 | -$10.03M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.50M | -260.9% | -634.8% |
| June 30, 2025 | -$2.38M | +74.2% | -190.4% |
| March 31, 2025 | $2.63M | +183.4% | +154.4% |
| September 30, 2024 | -$4.85M | +80.6% | +47.5% |
| June 30, 2024 | -$9.23M | +78.0% | -192.2% |
| March 31, 2024 | -$3.16M | +90.4% | +87.4% |
| September 30, 2023 | -$25.01M | +40.3% | +40.5% |
| June 30, 2023 | -$42.06M | +25.4% | -28.4% |
- HERON THERAPEUTICS, INC. /DE/ showed a decrease of -48.7% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, HERON THERAPEUTICS, INC. /DE/’s net income has declined by 101.4% (from -$10.03 million to -$20.20 million).
- The most recent figure is from HERON THERAPEUTICS, INC. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: